What is Brittle Diabetes?
Brittle diabetes refers to a rare and severe form of diabetes characterized by extreme, unpredictable glycemic instability with frequent episodes of hypoglycemia and/or hyperglycemia (including diabetic ketoacidosis) that constantly disrupt the patient's life and often require repeated hospitalizations, despite appropriate insulin management. 1
Core Definition and Characteristics
The term "brittle" describes patients whose lives are constantly disrupted by severe glycemic instability that cannot be attributed to simple management failure 2. This affects approximately 3 per 1,000 insulin-dependent diabetic patients 3. The condition is defined by:
- Chaotic glycemic profiles with greater and more unpredictable variation than in stable diabetes patients
- Failure to achieve control even with closely supervised intensive insulin regimens, including continuous subcutaneous or intravenous insulin infusion
- Recurrent acute complications leading to frequent hospital admissions
- Dramatically compromised quality of life and premature chronic complications 2
Clinical Presentations
Brittle diabetes manifests in three distinct forms 3:
- Recurrent diabetic ketoacidosis - the most common presentation
- Predominant hypoglycemic forms - characterized by severe, unpredictable hypoglycemia
- Mixed instability - alternating between both extremes
Four Life-Stage Groups
Modern understanding recognizes brittle diabetes occurs in four specific life stages, each with distinct characteristics 1:
1. Young Patients with Psychiatric Comorbidities
- Associated with bulimia, depression, and other psychiatric diseases
- Often involves manipulative behavior or factitious disease (insulin omission)
- Historically described in young women with psychosocial instability 4, 5
- Cluster B personality disorders (borderline, histrionic, narcissistic) are more prevalent 6
2. Patients with Underlying Medical Conditions
- Another medical condition disrupts insulin sensitivity or glucose utilization
- Includes malabsorption, certain drugs (alcohol, antipsychotics), defective insulin absorption
- Delayed gastric emptying from autonomic neuropathy is a major cause
- Defects in counterregulatory hormones (glucocorticoid, glucagon) 3
3. Geriatric Type 1 Diabetes (Largest Group)
- Develops severe instability due to frailty, chronic renal failure, dementia, vision loss
- Loss of hypoglycemia counterregulation
- Unintentional insulin omission or dosing errors
- Increasing insulin sensitivity with aging 1, 7
4. Insulin Access and Food Insecurity
- Lack of reliable insulin access
- Associated food insecurity
- Seen worldwide in resource-limited settings 1
Key Clinical Pitfalls
Critical distinction: Patients with brittle diabetes are NOT adequately controlled even by closely supervised, intensive insulin regimens 2. This distinguishes true brittle diabetes from simple poor compliance or inadequate management.
Important caveat: The term "brittle" should not be applied to patients in the hospital setting where multiple risk factors for hypoglycemia exist (altered nutritional state, heart failure, renal/liver disease, infection) 4. These represent situational instability, not true brittle diabetes.
Underlying Pathophysiology
There is always a specific, identifiable etiology causing brittle diabetes 8. The most common causes are:
- Psychological abnormalities (most common overall)
- Gastroparesis from autonomic neuropathy
- Severe systemic insulin resistance
- Impaired glucose counterregulation
- Factitious disease (deliberate insulin manipulation)
Management Principles
Therapy must always be directed at correcting the underlying pathogenic factor(s) 8. Key management strategies include:
- Extensive metabolic and psychological testing is required to identify the specific etiology
- Empirical therapy and invasive procedures are contraindicated without identifying the cause
- Team approach involving multiple disciplines is essential 2
- Continuous subcutaneous insulin infusion (pump therapy) can be effective, even in elderly patients 7
- Islet transplantation should be considered for severe hypoglycemic unawareness with BMI <25 and normal renal function 3
Approximately 50% of brittle diabetic patients respond to specific etiologic treatment once the underlying cause is identified and addressed 8.